Showing 9,501 - 9,520 results of 30,886 for search '(( 50 ((we decrease) OR (mean decrease)) ) OR ( 100 ((ng decrease) OR (a decrease)) ))', query time: 1.12s Refine Results
  1. 9501
  2. 9502
  3. 9503

    Trend Forecast for IHD from 2024 to 2050. by Zhuo Zhang (72795)

    Published 2025
    “…</p><p>Results</p><p>From 1990 to 2023, the age-standardized incidence rate (ASIR) and prevalence rate (ASPR) of IHD in China exhibited an upward trend. The ASIR per 100,000 increased from 109.7 (95% uncertainty interval [UI]: 93–128) to 110.3 (95% UI: 89–131), while the age-standardized mortality rate (ASMR) decreased from 126.8 (95% UI: 92–163) to 109.5 (95% UI: 94–127), mirroring global trends. …”
  4. 9504

    Data. by Zhuo Zhang (72795)

    Published 2025
    “…</p><p>Results</p><p>From 1990 to 2023, the age-standardized incidence rate (ASIR) and prevalence rate (ASPR) of IHD in China exhibited an upward trend. The ASIR per 100,000 increased from 109.7 (95% uncertainty interval [UI]: 93–128) to 110.3 (95% UI: 89–131), while the age-standardized mortality rate (ASMR) decreased from 126.8 (95% UI: 92–163) to 109.5 (95% UI: 94–127), mirroring global trends. …”
  5. 9505

    The fit of the model to the calibration data for CETP deficiency: HDL-C (panel A), ApoA-I (panel B), LDL-CE (panel C) and VLDL-CE (panel D). by James Lu (534847)

    Published 2014
    “…The model simulation curves were obtained by decreasing the 3 parameters representing CETP activity from 100% to 0% of those corresponding to the nominal subject.…”
  6. 9506
  7. 9507
  8. 9508
  9. 9509
  10. 9510
  11. 9511
  12. 9512
  13. 9513
  14. 9514

    Reduced <i>ccna2</i> and <i>ccnd1</i> expression in <i>ddb1</i><sup><i>m863</i></sup> mutant embryos. by Zhilian Hu (777443)

    Published 2015
    “…<p>(A-D) Expression pattern of <i>ccna2</i> in wild type siblings. …”
  15. 9515

    cGMP-reducing effects of thrombin in the presence of pharmacological modulators of the nitric oxide-cGMP pathway. by Katrin F. Nickel (421608)

    Published 2013
    “…<p>(A) Direct sGC-stimulator BAY 41–2272 (1 µM) und NO donor DETA NONOate (100 µM) elevate cGMP, but the prolonged thrombin challenge (0.3 nM) over 14 hours still reduces cGMP (white bars: controls; grey bars: thrombin). …”
  16. 9516
  17. 9517
  18. 9518

    Column-based Technology for CD9-HPLC Immunoaffinity Isolation of Serum Extracellular Vesicles by Jianhui Zhu (678784)

    Published 2021
    “…The CD9-HPLC-IAC method achieved EV isolation from 40 μL of serum in 30 min with a yield of 8.0 × 10<sup>9</sup> EVs, where EVs were further processed with a postcolumn cleaning step using the 50 kDa molecular weight cut-off filter for the buffer exchange, concentration, and reduction of potentially coeluting serum proteins. …”
  19. 9519
  20. 9520

    Blocking of DL1-platelet binding by Hsa-BR in whole human blood. by Lingquan Deng (669704)

    Published 2014
    “…(C–E) Whole blood with different concentrations of Hsa-BR added first, followed by DL1-Cy3 and CD41a-APC. Increasing amount of Hsa-BR results in decreasing count of DL1-bound platelets (Q2 percentages) and increasing numbers of free bacteria (Q3 percentages). …”